The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Proactis Holdings plc

21 Jun 2021 17:36

RNS Number : 6118C
PROACTIS Holdings PLC
21 June 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

PROACTIS HOLDINGS PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PROACTIS HOLDINGS PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

21 JUNE 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a. Interests in Proactis Holdings PLC's ordinary shares of 10p each held by the directors of Proactis Group PLC

 

Director

Number of ordinary shares

% of issued share capital

Rodney Potts

8,995,427

9.42

Alan Aubrey

1,362,926

1.43

Timothy Sykes

 

 

 

382,736

0.40

Nicholas Brown

67,415

0.07

Richard Hughes

15,000

0.02

Total

10,823,504

11.33

 

 

 

b. Interests of Directors of Proactis Holdings PLC under the Proactis Holdings PLC Executive LTIP

 

 

Name

Description of award

Number ofProactis Holdings PLC relevantsecurities

Exercise price

Grant date

Vesting date

Richard Hughes

LTIP award

1,271,785

£0.10

30 April 2021

30 April 2024

Tim Sykes

LTIP award

3,815,355

£0.10

30 April 2021

30 April 2024

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

21 June 2021

Contact name:

Richard Hughes

Telephone number:

01937 545 070

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUAONRAOUNUAR
Date   Source Headline
28th Jul 20217:00 amRNSCancellation - Proactis Holdings plc
27th Jul 20213:05 pmRNSScheme Effective
27th Jul 20217:30 amRNSSuspension - Proactis Holdings plc
26th Jul 20218:06 amRNSExercise of Options, PDMR Shareholding & TVR
23rd Jul 20212:25 pmRNSExercise of Options, PDMR Shareholding & TVR
23rd Jul 20212:00 pmRNSCourt Sanction of Scheme & Suspension
21st Jul 20215:30 pmRNSProactis Holdings
20th Jul 20214:25 pmRNSResults of Court Meeting and General Meeting
15th Jul 20213:13 pmRNSHolding(s) in Company
15th Jul 20219:18 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
12th Jul 20211:37 pmRNSForm 8.3 - [PROACTIS HOLDING PLC]
9th Jul 20219:22 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
8th Jul 20219:47 amRNSForm 8.3 - [PROACTIS HOLDINGS PLC]
1st Jul 20218:28 amRNSForm 8.3 - PROACTIS HOLDINGS PLC
29th Jun 20217:00 amRNSConclusion of cyber security incident
28th Jun 20215:55 pmRNSPosting of Scheme Document
21st Jun 20215:36 pmRNSForm 8 (OPD) Proactis Holdings plc
21st Jun 20217:00 amRNSbePayd Strategic Contract Win
18th Jun 20217:00 amRNSForm 8 (OPD) - Proactis Holdings Plc
11th Jun 20217:11 amRNSUpdate re. Recommended Acquisition of Proactis
11th Jun 20217:00 amRNSRecommended acquisition of Proactis Holdings
28th May 20219:12 amRNSTimetable for publication of the Scheme Document
21st May 20213:37 pmRNSNotice of cyber security incident
18th May 20217:00 amRNSStrategic Contract Win
17th May 20214:58 pmRNSUpdate on irrevocable undertakings
17th May 202111:10 amRNSForm 8.3 - Proactis Holdings plc
17th May 20219:13 amRNSFORM 8 (OPD) - Proactis Holdings Plc
13th May 202110:18 amBUSForm 8.3 - Proactis Holdings Plc
11th May 20215:22 pmRNSHolding(s) in Company
10th May 20213:03 pmRNSForm 8.3 - Proactis Holdings Plc
10th May 20217:00 amRNSForm 8.3 - Proactis Holdings PLC
7th May 202111:57 amRNSForm 8.3 - Proactis Holdings plc
6th May 20215:01 pmRNSForm 8.3 - Proactis Holdings PLC
6th May 202110:54 amRNSForm 8 (OPD) Proactis Holdings plc
5th May 20215:27 pmRNSHolding(s) in Company
5th May 20213:29 pmRNSForm 8.3 - Proactis Holdings Plc
5th May 20212:20 pmRNSForm 8.3 - Proactis Holdings PLC
5th May 202111:47 amRNSForm 8.3 - Proactis plc / Cafe Bidco Limited
4th May 20215:03 pmRNSForm 8.3 - Proactis Holdings Plc
4th May 20214:55 pmRNSHolding(s) in Company
4th May 20212:51 pmRNSForm 8 (DD) - Proactis Holdings Plc
4th May 20211:38 pmRNSForm 8.3 - Proactis / Cafe Bidco Limited
4th May 20211:32 pmRNSForm 8.3 - Proactis / Cafe Bidco Limited
4th May 20219:55 amRNSForm 8.3 - Proactis Holdings Plc
4th May 20217:00 amRNSInvestment in Vertu Motors plc & Notice of Results
30th Apr 20214:40 pmRNSSecond Price Monitoring Extn
30th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20214:24 pmRNSNew LTIP, Grant of Options & PDMR Shareholdings
30th Apr 20214:06 pmRNSRecommended Acquisition of Proactis
30th Apr 20214:00 pmRNSRecommended acquisition of Proactis Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.